Aromatase in bone: Roles of Vitamin D3 and androgens

Journal of Steroid Biochemistry and Molecular Biology

Volumn 86, Issue 3-5, 2003, Pages 393-397

  Yanase, Toshihiko ^a,b   Suzuki, Shizu ^a   Goto, Kiminobu ^a,b   Nomura, Masatoshi ^a,b   Okabe, Taijiro ^a,b   Takayanagi, Ryoichi ^a,b   Nawata, Hajime ^a,b  

^a KYUSHU UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

25 DIHYDROXYVITAMIN D3; 3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; ANDROGEN; ANDROSTENEDIONE; AROMATASE; CALCITRIOL; COLECALCIFEROL; COLECALCIFEROL DERIVATIVE; CYCLIC AMP; CYTOCHROME P450; DEXAMETHASONE; ESTRADIOL; ESTROGEN; ESTRONE; GLUCOCORTICOID; LUCIFERASE; MESSENGER RNA; METRIBOLONE; PRASTERONE; PRASTERONE SULFATE; RETINOIC ACID; SEX HORMONE; STEROID; TESTOSTERONE; UNCLASSIFIED DRUG;

ADRENAL GLAND; AROMATIZATION; BONE; BONE CELL; BONE DENSITY; BONE MINERAL; BONE REMODELING; CELL CULTURE; CIRCULATION; CLINICAL TRIAL; CONFERENCE PAPER; CORRELATION ANALYSIS; DRUG EFFECT; ENZYME ACTIVITY; ESTRADIOL BLOOD LEVEL; ESTROGEN SYNTHESIS; ESTRONE BLOOD LEVEL; EXON; FIBROBLAST; GENE CONSTRUCT; GENE EXPRESSION; GENETIC TRANSFECTION; HORMONE BLOOD LEVEL; HUMAN; IN VIVO STUDY; MENOPAUSE; NONHUMAN; OSTEOBLAST; OSTEOPOROSIS; OVARIECTOMY; POSTMENOPAUSE; PROMOTER REGION; REGULATORY MECHANISM;

EID: 0242626130     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(03)00349-2     Document Type: Conference Paper

References (21)

1. Oz O.K., Zerwekh J.E., Fisher C., Graves K., Nanu L., Millsaps R., Simpson E.R. Bone has a sexually dimorphic response to aromatase deficiency. J. Bone Miner. Res. 15:2000;507-514.
2. Oz O.K., Hirasawa G., Lawson J., Nanu L., Constantinescu A., Antich P.P., Mason R.P., Tsyganov E., Parkey R.W., Zerwekh J., Simpson E.R. Bone phenotype of the aromatase deficient mouse. J. Steroid Biochem. Mol. Biol. 79:2001;49-59.
3. Miyaura C., Toda K., Inada M., Ohshiba T., Matsumoto C., Okada T., Ito M., Shizuta Y., Ito A. Sex- and age-related response to aromatase deficiency in bone. Biochem. Biophys. Res. Commun. 280:2001;1062-1068.
4. Morishima A., Grumbach M.M., Simpson E.R., Fisher C., Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J. Clin. Endocrinol. Metab. 80:1995;3689-3698.
5. Carani C., Qin K., Simoni M., Faustini-Fustini M., Serpente S., Boyd J., Korach K.S., Simpson E.R. Effect of testosterone and estradiol in a man with aromatase deficiency. N. Engl. J. Med. 337:1997;91-95.
6. Deladoey J., Fluck C., Bex M., Yoshimura N., Harada N., Mullis P.E. Aromatase deficiency caused by a novel P450arom gene mutation: impact of absent estrogen production on serum gonadotropin concentration in a boy. J. Clin. Endocrinol. Metab. 84:1999;4050-4054.
7. Nawata H., Tanaka S., Tanaka S., Takayanagi R., Dsakai Y., Yanase T., Ikuyama S., Haji M. Aromatase in bone cells: association with osteoporosis in postinenopausal women. J. Steroid Biochem. Mol. Biol. 53:1995;165-174.
8. 3 enhances the enzymatic activity and expression of the messenger ribonucleic acid for the aromatase cytochrome P450 synergistically with dexamethasone depending on the Vitamin D receptor level in cultured human osteoblasts. Encdocrinology. 137:1996;1860-1869.
9. Labrie F., Diamond P., Cusan L., Gomez J.L., Belanger A., Candas B. Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women. J. Clin. Endocrinol Metab. 82:1997;3498-3505.
10. Baulieu E.E., Thomas G., Legrain S., Lahlou N., Roger M., Debuire B., Faucounau V., Girard L., Hervy M.P., Latour F., Leaud M.C., Mokrane A., Pitti-Ferrandi H., Trivalle C., de Lacharriere O., Nouveau S., Rakoto-Arison B., Souberbielle J.C., Raison J., Le Bouc Y., Raynaud A., Girerd X., Forette F. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. Proc. Natl. Acad. Sci. U.S.A. 97:2000;4279-4284.
11. Kahn A.J., Hallooras B. Dehydroepiandrosterone supplimentation and bone turnover in middle-aged to elderly men. Clin. Endocrinol. Metab. 87:2002;1544-1549.
12. Windahl S.H., Andersson G., Gustafsson J.A. Elucidation of estrogen receptor function in bone with the use of mouse models. Trends Endocrinol. Metab. 13:2002;95-200.
13. Smith E.P., Boyd J., Frank G.R., Takahashi H., Cohen R.M., Specker B., Williams T.C., Lubahn D.B., Korach K.S. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. New Engl. J. Med. 331:1994;1056-1061.
14. Davis S.R., McCloud P., Strauss B.J., Burger H. Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas. 21:1995;227-236.
15. Benz D.J., Haussler M.R., Thomas M.A., Speelman B., Komm B.S. High-affinity androgen binding and androgenic regulation of alpha 1(I)- procollagen and transforming growth factor-beta steady state messenger ribonucleic acid levels in human osteoblast-like osteosarcoma cells. Endocrinology. 128:1991;2723-2730.
16. Mizuno Y., Hosoi T., Inoue S., Ikegami A., Kaneki M., Akedo Y., Nakamura T., Ouchi Y., Chang C., Orimo H. Immunocytochemical identification of androgen receptor in mouse osteoclast-like multinucleated cells. Calcif. Tissue Int. 54:1994;325-326.
17. Lea C.K., Flanagan A.M. Ovarian androgens protect against bone loss in rats made oestrogen deficient by treatment with ICI 182,780. J. Endocrinol. 160:1999;111-117.
18. Yeh S., Tsai M.-Y., Xu Q., Mu X.-M., Lardy H., Huang K., Lin H., Yeh S.-D., Atsuwajiri S., Zhou X., Xing L., Boyce B.F., Hung M.-C., Zhang S., Gan L., Chang C. Generation and characterization of androgen receptor knockout (ARKO) mice: an in vivo model for the study of androgen functions in selective tissues. Proc. Natl. Acad. Sci. U.S.A. 99:2002;13498-13503.
19. Sato T., Matsumoto T., Yamada T., Watanabe T., Kawanop H., Kato S. Late onset of obesity in male androgen receptor-deficient (ArKO) mice. Biochem. Biophys. Res. Commun. 300:2003;167-171.
20. Khosla S., Atkinson E.J., Dunstan C.R., O'fallon W.M. Effect of estrogen versus testosterone on circulating osteoprotegrin and other cytokine levels in normal elderly men. J. Clin. Endocrinol. Metab. 87:2002;1550-1554.
21. Marcus R., Leary D., Schneider D.L., Shane E., Favus M., Quigley C.A. The contribution of testosterone to skeletal development and maintenance: lessons from the androgen insensitivity syndrome. J. Clin. Endocrinol. Metab. 85:2000;1032-1037.